Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/09/1995 | CA2169950A1 Monoclonal antibody that induces apoptosis |
03/09/1995 | CA2169645A1 Non-nucleotide containing enzymatic nucleic acid |
03/09/1995 | CA2169557A1 Treatment of human tumors by genetic transformation of human tumor cells |
03/09/1995 | CA2169466A1 Methods for screening antiestrogen compounds |
03/09/1995 | CA2169094A1 Medium chain-specific thioesterases |
03/09/1995 | CA2168565A1 T cell epitopes of ryegrass pollen allergen |
03/09/1995 | CA2158934A1 Methods of suppressing immune response by gene therapy |
03/09/1995 | CA2158933A1 Methods of suppressing graft rejection |
03/09/1995 | CA2158932A1 Methods of suppressing autoimmune response |
03/09/1995 | CA2118990A1 Catalytic antibodies hydrolyzing acylated carbohydrates with a regio-and stereoselective manner |
03/08/1995 | EP0641861A2 Process for producing hydrophobic polypeptides, proteins or peptides |
03/08/1995 | EP0641860A2 A strain of saccharomyces cerevisiae expressing the gene encoding potassium transporter mink |
03/08/1995 | EP0641801A2 Catalytic antibodies hydrolyzing acylated carbohydrates with a region- and stereoselective manner |
03/08/1995 | EP0641391A1 Loop structures |
03/08/1995 | EP0641390A1 Chemical method for the analysis of dna sequences. |
03/08/1995 | EP0641386A1 Human 5ht-1b receptor (serotonin receptor), process for preparing the same and its uses |
03/08/1995 | EP0641385A1 Development of dna probes and immunological reagents of human tumor associated antigens |
03/08/1995 | EP0641384A1 VIRUS RESISTANT PLANTS CONTAINING INDUCIBLE CYTOTOXIC mRNAs |
03/08/1995 | EP0641359A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects |
03/08/1995 | EP0641353A1 Anti-sense oligonucleotides for isotype-specific suppression of immunoglobulin production |
03/08/1995 | EP0641215A1 Protease-resistant thrombomodulin analogs |
03/08/1995 | EP0641212A1 Method and reagent for inhibiting cancer development |
03/08/1995 | EP0484382B1 Feline calicivirus capsid protein and nucleotide sequence |
03/08/1995 | EP0295286B1 Method for the production of salmon growth hormone using a synthetic gene |
03/08/1995 | CN1099802A Tumor necrosis factor muteins |
03/08/1995 | CN1099801A Peptides |
03/08/1995 | CN1099800A Fungus resistant plants |
03/08/1995 | CN1099799A Process for preparing and purifying alpha-interferon |
03/08/1995 | CN1099798A Hepatitis a virus vaccine |
03/08/1995 | CA2117616A1 Strain of saccharomyces cerevisiae expressing the gene encoding potassium transporter mink |
03/07/1995 | US5395929 Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor |
03/07/1995 | US5395928 Elution with controlled concentration of buffer with soft base counterion |
03/07/1995 | US5395927 DNA-fragment having the cyclodextrin glycosyltranferase gene |
03/07/1995 | US5395922 Yeast processing system |
03/07/1995 | US5395767 Isolated nucleic acid |
03/07/1995 | US5395764 Promoter of the gene which codes for the pilinic subunit fim3 of Bordetella pertussis and its use for the expression in Bordetella of the genes which code for a protein of interest |
03/07/1995 | US5395763 Chromosomal expression vector |
03/07/1995 | US5395761 Plasmid pHKY334, an expression vector for EK-BGH and host cells transformed therewith |
03/07/1995 | US5395760 Isolated dna sequence encoding selected amino acid sequences |
03/07/1995 | US5395759 Vaccines, medical diagnosis |
03/07/1995 | US5395756 Production of acidic FGF protein |
03/07/1995 | US5395750 Constructing a plurality of synthetic genes, expressing proteins encoded by genes in a microorganism and contacting proteins with antigen to obtain antibody binding to the antigen |
03/07/1995 | US5395614 Vaccines reducing severity of blood-stage malaria |
03/03/1995 | CA2131433A1 Mice deficient in neurotrophin receptors |
03/02/1995 | WO1995006253A1 Assay device with captured particle reagent |
03/02/1995 | WO1995006250A1 Molecular clones producing recombinant dna antigens of the hards virus |
03/02/1995 | WO1995006247A1 Natural killer cell-specific antigen and antibodies that identify the same |
03/02/1995 | WO1995006137A1 Detection of genes |
03/02/1995 | WO1995006129A2 Transfection process |
03/02/1995 | WO1995006128A2 Fertile, transgenic maize plants and methods for their production |
03/02/1995 | WO1995006127A1 Method for the production of transgenic cereals |
03/02/1995 | WO1995006126A1 Production of trehalose in plants |
03/02/1995 | WO1995006124A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
03/02/1995 | WO1995006123A1 Detection and prevention of mycoplasma hominis infection |
03/02/1995 | WO1995006122A2 Recombinant alternaria alternata allergenes |
03/02/1995 | WO1995006121A2 Recombinant cladosporium herbarum allergens |
03/02/1995 | WO1995006120A1 Recombinant cells from the monocyte-macrophage cell line for gene therapy |
03/02/1995 | WO1995006119A1 Recombinant humanized anti-human immunodeficiency virus antibody |
03/02/1995 | WO1995006118A1 Expression control sequences of the p-selectin gene |
03/02/1995 | WO1995006117A1 Human 5-ht2 receptor |
03/02/1995 | WO1995006113A1 Novel tyrosine kinase |
03/02/1995 | WO1995006067A1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
03/02/1995 | WO1995006065A1 Cytokines that bind the cell surface receptor hek |
03/02/1995 | WO1995006064A1 Refolding of polypeptides like recombinant insulin-like growth factor igf-i |
03/02/1995 | WO1995006059A1 Aqueous multiple-phase isolation of polypeptide |
03/02/1995 | WO1995006056A1 Bridged polycationic polymer-oligonucleotide conjugates and methods for preparing same |
03/02/1995 | WO1995006055A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors |
03/02/1995 | WO1995005853A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides |
03/02/1995 | WO1995005851A1 HIV vif-RELATED COMPOSITIONS, AND PROPHYLACTIC AND THERAPEUTIC USES THEREOF |
03/02/1995 | WO1995005850A1 Campylobacter jejuni antigens, and methods for their production and use |
03/02/1995 | WO1995005847A1 Accessory factor function for interferon gamma and its receptor |
03/02/1995 | WO1995005835A1 Gene therapy for solid tumors, papillomas and warts |
03/02/1995 | WO1995005810A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
03/02/1995 | WO1995005750A1 Cell death regulator |
03/02/1995 | WO1995005738A1 Anticancer agents and apoptosis |
03/02/1995 | WO1995005732A1 Materials and methods for producing plants with single-sex flowers |
03/02/1995 | WO1995005731A1 Gene conferring disease resistance to plants |
03/02/1995 | WO1995003418A3 Recombinant bcg vaccines |
03/02/1995 | WO1995003414A3 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
03/02/1995 | WO1995003410A3 Guanylatcyclase activating peptide i (gcap-i) coding gene |
03/02/1995 | WO1995001437A3 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
03/02/1995 | WO1994029456A3 Herpes simplex virus type-2 protease |
03/02/1995 | WO1994025601A3 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
03/02/1995 | WO1993015229A3 Amplification of assay reporters by nucleic acid replication |
03/02/1995 | DE4425481A1 Melanoma-inhibiting protein |
03/02/1995 | DE4407859C1 Vector for liver-specific gene therapy |
03/02/1995 | DE4333805A1 Process for extraction of nucleic acids and method for detecting specified nucleic acid sequences |
03/02/1995 | DE4325262A1 Resistance inducer, process for its preparation, use for controlling pests |
03/02/1995 | CA2623540A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
03/02/1995 | CA2170356A1 Recombinant cladosporium herbarum allergens |
03/02/1995 | CA2170355A1 Recombinant alternaria alternata allergenes |
03/02/1995 | CA2170352A1 Natural killer cell-specific antigen and antibodies that identify the same |
03/02/1995 | CA2170260A1 Fertile, transgenic maize plants and methods for their production |
03/02/1995 | CA2170249A1 Assay device with captured particle reagent |
03/02/1995 | CA2170159A1 Recombinant cells from the monocyte-macrophage cell ligne for gene therapy |
03/02/1995 | CA2169941A1 Expression control sequences of the p-selectin gene |
03/02/1995 | CA2169851A1 Cytokines that bind the cell surface receptor hek |
03/02/1995 | CA2169849A1 Accessory factor function for interferon gamma and its receptor |
03/02/1995 | CA2169828A1 Transfection process |
03/02/1995 | CA2169755A1 Detection and prevention of mycoplasma hominis infection |